Current Drug Targets


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia

Volume:20   Issue: 16
Pp: 1603-1623
Eman M. Hamed, Mohamed Hussein Meabed, Usama Farghaly Aly and Raghda R.S. Hussein*
DOI: 10.2174/1389450120666190726155733
Published on: 13 November, 2019

Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle

Volume:20   Issue: 16
Pp: 1624-1635
Jobin Jose, Aaron Mathew Thomas, Darewin Mendonsa, Mohammad M. Al-Sanea, Md. Sahab Uddin, Della Grace Thomas Parambi, R Narayana Charyulu and Bijo Mathew*
DOI: 10.2174/1389450120666190729121747
Published on: 13 November, 2019

Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors

Volume:20   Issue: 16
Pp: 1636-1651
Bing-Yi Zhang, Dan-Ping Chai, Yi-Hang Wu*, Li-Peng Qiu, Yong-Yong Zhang, Zi-Hong Ye and Xiao-Ping Yu
DOI: 10.2174/1389450120666190729115646
Published on: 13 November, 2019

Advances in the Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 2: Focus on Schizophrenia

Volume:20   Issue: 16
Pp: 1652-1669
Artur Świerczek, Agnieszka Jankowska, Grażyna Chłoń-Rzepa, Maciej Pawłowski and Elżbieta Wyska*
DOI: 10.2174/1389450120666190801114210
Published on: 13 November, 2019

Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis

Volume:20   Issue: 16
Pp: 1670-1679
Olorunfemi A. Oshagbemi, Jephthah O. Odiba, Abraham Daniel and Ismaeel Yunusa*
DOI: 10.2174/1389450120666190808141625
Published on: 13 November, 2019

Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation

Volume:20   Issue: 16
Pp: 1680-1694
Ammu Prasanna Kumar*, Sungmun Lee and Suryani Lukman*
DOI: 10.2174/1389450120666190719164316
Published on: 13 November, 2019

Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis open access plus

Volume:20   Issue: 16
Pp: 1695-1701
Tetsumei Urano*, Yuko Suzuki, Takayuki Iwaki, Hideto Sano, Naoki Honkura and Francis J. Castellino
DOI: 10.2174/1389450120666190715102510
Published on: 13 November, 2019

Acknowledgements to Reviewers free to download

Volume:20   Issue: 16
Pp: 1702-1703

DOI: 10.2174/138945012016191017121828
Published on: 13 November, 2019